← Back to news
NewsFRONTIERS IN NEUROLOGYFriday, April 17, 2026 · April 17, 2026

The effect of statins on the survival of patients with amyotrophic lateral sclerosis: a meta-analysis.

WHY IT MATTERS

Recent peer-reviewed research on Amyotrophic Lateral Sclerosis (ALS) that may be relevant for patients and caregivers.

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease with limited disease-modifying therapies and a poor overall prognosis. Statins, are commonly used for dyslipidemia, and have been proposed to exert cholesterol-independent actions including anti-inflammatory and potential...

Read on PubMed
Read the original at Frontiers in neurology
ResearchPubMedAmyotrophic Lateral Sclerosis (ALS)

Related conditions

Amyotrophic Lateral Sclerosis (ALS)

Related news

Int J Circumpolar Health · -222 days ago
A population-based legacy study of myasthenia gravis in Iceland: insights from a small Arctic nation
Published in Int J Circumpolar Health. Hjaltason H et al.
Ther Adv Rare Dis · -192 days ago
Could an outcome-based agreement be operationalized using real-world data from the Canadian Neuromuscular Disease Registry? Perspectives from an expert-led assessment in spinal muscular atrophy
Published in Ther Adv Rare Dis. Mitha A et al.
Health Inf Sci Syst · -192 days ago
PhenoRareAI: Phenotype-based intelligent diagnosis for rare neuromuscular disorders of glycogen storage disease and spinal muscular atrophy
Published in Health Inf Sci Syst. Zhai W et al.
J Allergy Clin Immunol Glob · -39 days ago
Emerging trends and research hot spots in inborn error of immunity: A bibliometric perspective
Published in J Allergy Clin Immunol Glob. Alblooshi H et al.